Most Viewed Posts Clear Filters Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested 2 February 2018 The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis 6 June 2018 Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model 25 January 2019 Clear Filters Oral Communications Past Events2 September 2026 The 2060 Longevity Forum 2026 – Aix en Provence | 2-3 September Concussions Past Events24 August 2026 ESCC 2026 – Nice | 10-12 June Alzheimer Past Events Posted Communications23 August 2026 AAIC 2026 – London | 12-15 July Alzheimer22 August 2026 REGEnLIFE: a new step towards a practical and accessible treatment to address the public health challenges posed by Alzheimer’s disease. Alzheimer22 August 2026 Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes
